stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Return on assets
MiniMed Group, Inc.'s return on assets over the twelve months to 31 July 2026 was −6.27%, up 1.3 percentage points from fiscal 2026 (−7.54%). That is below the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | −7.54% | 2.60 |
| FY2025 | −10.1% | (10.14) |
| FY2024 | 0.00% | — |
Return on assets against peers
| Company | Return on assets |
|---|---|
| NVST Envista Holdings Corporation compare | 11.3% |
| MMSI Merit Medical Systems, Inc. compare | 5.76% |
| STVN Stevanato Group S.p.A. compare | 5.50% |
| ATRC AtriCure, Inc. compare | 2.20% |
| ICUI ICU Medical, Inc. compare | 1.50% |
| BLCO Bausch + Lomb Corporation compare | −0.80% |
| MMED MiniMed Group, Inc. | −6.27% |
| TFX Teleflex Incorporated compare | −14.6% |
| PLSE Pulse Biosciences, Inc compare | −54.0% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement